Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Pharmacists share key insights about the use of ADCs for treatment of breast cancer.

Pharmacy Focus: Oncology Edition - A Conversation About Biden's Cancer Moonshot Program

Pharmacy Focus: Oncology Edition - PARP Inhibitors in Ovarian Cancer

Pharmacy Focus: Oncology Edition - What You Missed at ASCO 2022

Pharmacy Focus: Oncology Edition - A Look Ahead at the Pipeline for Melanoma

Pharmacy Focus: Oncology Edition - An Update on Prostate Cancer and the Growing Role of Pharmacists

Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia

Pharmacy Focus: Oncology Edition - Pharmacists Play Key Role in Non–Small Cell Lung Cancer

Pharmacy Focus: Oncology Edition - Breast Cancer Treatments Are Rapidly Expanding

Pharmacy Focus: Oncology Edition - Consider Treatment Sequences Carefully in Myeloma

Pharmacy Focus: Oncology Edition - A Look Into Psychedelic Medicines for Oncology Care

Pharmacy Focus: Oncology Edition - PARP Inhibitors Are Changing the Game in Prostate Cancer

Pharmacy Focus: Oncology Edition- A Practical, Real-World Understanding of the Enhancing Oncology Model

Pharmacy Focus: Oncology Edition- Latest Updates in Non-Small Cell Lung Cancer Treatment

Pharmacy Focus: Oncology Edition- Integrating Oncology Pharmacists into Multidisciplinary Care Teams for Improved Patient Outcomes

Pharmacy Focus: Oncology Edition- Pharmacists Pivotal Role in Driving Clinical Trial Research

Pharmacy Focus: Oncology Edition- Benefits of Subcutaneous Amivantamab for Lung Cancer Treatment

Pharmacy Focus - Oncology Edition: The Link Between Gut Health and Colon Cancer, Exploring the Wellness Innovation Network

Pharmacy Focus- Oncology Edition: Delayed Breast Cancer Screenings

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma

From Screening to Survival: The Pharmacist’s Role in Colorectal Cancer

Now Viewing

Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Related Videos

Related Content

Advertisement

July 14th 2025

Adjuvant Trastuzumab Emtansine Plus Trastuzumab Improved Disease-Free, Overall Survival in HER2+ Early Breast Cancer

Alexandra Gerlach, Associate Editor

July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor

July 14th 2025

Riliprubart Receives FDA Orphan Drug Designation for AMR in Solid Organ Transplantation

Gillian McGovern, Associate Editor

July 1st 2025

An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor

July 14th 2025

Publication Bias—as Old as Science Itself?

Curtis E. Haas, PharmD, FCCP

July 14th 2025

TRE-5151 Receives FDA Fast Track Designation in Combination With Radiation Therapy for Prostate Cancer

Kennedy Ferruggia, Assistant Editor

Related Content

Advertisement

July 14th 2025

Adjuvant Trastuzumab Emtansine Plus Trastuzumab Improved Disease-Free, Overall Survival in HER2+ Early Breast Cancer

Alexandra Gerlach, Associate Editor

July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor

July 14th 2025

Riliprubart Receives FDA Orphan Drug Designation for AMR in Solid Organ Transplantation

Gillian McGovern, Associate Editor

July 1st 2025

An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor

July 14th 2025

Publication Bias—as Old as Science Itself?

Curtis E. Haas, PharmD, FCCP

July 14th 2025

TRE-5151 Receives FDA Fast Track Designation in Combination With Radiation Therapy for Prostate Cancer

Kennedy Ferruggia, Assistant Editor